News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
377,851 Results
Type
Article (27958)
Company Profile (55)
Press Release (349838)
Multimedia
Podcasts (48)
Webinars (4)
Section
Business (103801)
Career Advice (1365)
Deals (18594)
Drug Delivery (66)
Drug Development (52135)
Employer Resources (98)
FDA (10533)
Job Trends (8837)
News (188967)
Policy (19879)
Tag
Academia (2048)
Academic (1)
Accelerated approval (2)
Adcomms (15)
Allergies (54)
Alliances (26697)
ALS (67)
Alzheimer's disease (1178)
Antibody-drug conjugate (ADC) (80)
Approvals (10572)
Artificial intelligence (147)
Autoimmune disease (14)
Automation (14)
Bankruptcy (214)
Best Places to Work (7224)
BIOSECURE Act (4)
Biosimilars (47)
Biotechnology (35)
Bladder cancer (69)
Brain cancer (17)
Breast cancer (173)
Cancer (1459)
Cardiovascular disease (136)
Career advice (1166)
Career pathing (21)
CAR-T (92)
Cell therapy (249)
Cervical cancer (16)
Clinical research (42319)
Collaboration (504)
Compensation (175)
Complete response letters (13)
COVID-19 (1564)
CRISPR (29)
C-suite (102)
Cystic fibrosis (60)
Data (1674)
Denatured (8)
Depression (31)
Diabetes (191)
Diagnostics (4795)
Digital health (8)
Diversity (1)
Diversity, equity & inclusion (23)
Drug discovery (78)
Drug pricing (75)
Drug shortages (18)
Duchenne muscular dystrophy (61)
Earnings (42878)
Editorial (22)
Employer branding (13)
Employer resources (80)
Events (49885)
Executive appointments (343)
FDA (11403)
Friedreich's ataxia (3)
Frontotemporal dementia (5)
Funding (409)
Gene editing (69)
Generative AI (10)
Gene therapy (237)
GLP-1 (498)
Government (3013)
Grass and pollen (5)
Guidances (58)
Healthcare (11434)
Huntington's disease (14)
IgA nephropathy (24)
Immunology and inflammation (64)
Indications (19)
Infectious disease (1659)
Inflammatory bowel disease (80)
Inflation Reduction Act (6)
Influenza (31)
Intellectual property (61)
Interviews (205)
IPO (8230)
IRA (30)
Job creations (1889)
Job search strategy (1040)
Kidney cancer (7)
Labor market (17)
Layoffs (235)
Leadership (7)
Legal (4618)
Liver cancer (40)
Lung cancer (209)
Lymphoma (103)
Machine learning (5)
Management (32)
Manufacturing (155)
MASH (74)
Medical device (7689)
Medtech (7690)
Mergers & acquisitions (10638)
Metabolic disorders (490)
Multiple sclerosis (50)
NASH (20)
Neurodegenerative disease (69)
Neuropsychiatric disorders (18)
Neuroscience (1551)
NextGen: Class of 2025 (3820)
Non-profit (2885)
Now hiring (32)
Obesity (234)
Opinion (142)
Ovarian cancer (40)
Pain (101)
Pancreatic cancer (50)
Parkinson's disease (98)
Partnered (15)
Patents (132)
Patient recruitment (72)
Peanut (26)
People (28471)
Pharmaceutical (21)
Pharmacy benefit managers (13)
Phase I (12281)
Phase II (18544)
Phase III (14728)
Pipeline (887)
Policy (84)
Postmarket research (1832)
Preclinical (5906)
Press Release (35)
Prostate cancer (75)
Psychedelics (15)
Radiopharmaceuticals (152)
Rare diseases (256)
Real estate (3210)
Recruiting (37)
Regulatory (13640)
Reports (25)
Research institute (1609)
Resumes & cover letters (183)
Rett syndrome (5)
RNA editing (3)
RSV (27)
Schizophrenia (50)
Series A (55)
Series B (41)
Service/supplier (2)
Sickle cell disease (40)
Special edition (5)
Spinal muscular atrophy (89)
Sponsored (20)
Startups (1869)
State (1)
Stomach cancer (5)
Supply chain (36)
Tariffs (19)
The Weekly (39)
Vaccines (379)
Venture capitalists (16)
Weight loss (153)
Women's health (13)
Worklife (9)
Date
Today (107)
Last 7 days (473)
Last 30 days (1599)
Last 365 days (19403)
2025 (6444)
2024 (20840)
2023 (23702)
2022 (30532)
2021 (32753)
2020 (31488)
2019 (27135)
2018 (20855)
2017 (19199)
2016 (18465)
2015 (21417)
2014 (15638)
2013 (12733)
2012 (13531)
2011 (13930)
2010 (12516)
Location
Africa (455)
Alabama (25)
Alaska (4)
Arizona (84)
Arkansas (8)
Asia (20710)
Australia (3937)
California (3484)
Canada (1127)
China (262)
Colorado (161)
Connecticut (148)
Delaware (85)
Europe (49359)
Florida (499)
Georgia (125)
Idaho (29)
Illinois (290)
India (16)
Indiana (183)
Iowa (6)
Japan (105)
Kansas (71)
Kentucky (16)
Louisiana (8)
Maine (52)
Maryland (469)
Massachusetts (2357)
Michigan (131)
Minnesota (191)
Missouri (57)
Montana (18)
Nebraska (15)
Nevada (41)
New Hampshire (39)
New Jersey (1164)
New Mexico (18)
New York (1119)
North Carolina (589)
North Dakota (4)
Northern California (1565)
Ohio (137)
Oklahoma (4)
Oregon (21)
Pennsylvania (768)
Puerto Rico (8)
Rhode Island (16)
South America (634)
South Carolina (11)
South Dakota (1)
Southern California (1342)
Tennessee (63)
Texas (583)
United States (13297)
Utah (117)
Virginia (85)
Washington D.C. (29)
Washington State (349)
West Virginia (3)
Wisconsin (26)
377,851 Results for "charles river laboratories pathology associates pai".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Charles River Laboratories Schedules First-Quarter 2025 Earnings Release and Conference Call
April 15, 2025
·
1 min read
Press Releases
Charles River Laboratories to Present at Barclays Global Healthcare Conference
March 11, 2025
·
1 min read
Press Releases
Charles River and Deciphex Extend Global Partnership to Expand Digital Pathology Offering with Exclusive Image Management Solutions
February 11, 2025
·
3 min read
Press Releases
Charles River Announces Inaugural Advanced Therapy Incubator Program Cohort
April 30, 2025
·
6 min read
Press Releases
FairJourney Biologics Acquires Charles River Laboratories South San Francisco Facility
March 4, 2025
·
2 min read
Press Releases
Charles River Leverages Advanced Technology to Expedite Oncology Drug Discovery and Development
April 22, 2025
·
6 min read
Press Releases
Charles River Laboratories to Present at J.P. Morgan Healthcare Conference
January 13, 2025
·
1 min read
Press Releases
Charles River Laboratories Announces Fourth-Quarter and Full-Year 2024 Results and Provides 2025 Guidance
February 19, 2025
·
20 min read
Business
Charles River and Deciphex Launch Patholytix Foresight, a Transformative AI-Powered Decision Support Tool for Toxicologic Pathology
Charles River Laboratories International, Inc. (NYSE: CRL) today announced the launch of Patholytix Foresight, a non-clinical artificial intelligence (AI) decision support tool developed in collaboration with Deciphex, an innovator in pathology AI.
April 11, 2024
·
3 min read
BioCapital
Charles River Laboratories Expands Access to CRADL® Contract Vivarium Space in Somerville
New turnkey research facility will provide AAALAC-accredited flexible vivarium space for Massachusetts biopharmaceutical hub Charles River Laboratories International, Inc. has announced the opening of a new Charles River Accelerator and Development Lab facility on Chestnut Street in Somerville, Massachusetts, an emerging life sciences hub.
June 6, 2024
·
3 min read
1 of 37,786
Next
